| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 3.32 | 0.02 (+0.61%) | 2.07 - 4.05 | 1.1 million |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
05/08/2013 4:01 PM ET
Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
05/01/2013 8:30 AM ET
Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
04/26/2013 7:45 AM ET